Product NDC: | 0409-1219 |
Proprietary Name: | Naloxone Hydrochloride |
Non Proprietary Name: | NALOXONE HYDROCHLORIDE |
Active Ingredient(s): | .4 mg/mL & nbsp; NALOXONE HYDROCHLORIDE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-1219 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA070257 |
Marketing Category: | ANDA |
Start Marketing Date: | 19870107 |
Package NDC: | 0409-1219-01 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0409-1219-01) > 10 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 0409-1219-01 |
Proprietary Name | Naloxone Hydrochloride |
Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0409-1219-01) > 10 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 0409-1219 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | NALOXONE HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 19870107 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | NALOXONE HYDROCHLORIDE |
Strength Number | .4 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |